导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.91% | 1498/3712 |
| 近一周 | -0.07% | 718/4228 |
| 近一月 | 5.25% | 42/4196 |
| 近一季 | 5.96% | 240/4044 |
| 近半年 | 5.20% | 627/3824 |
| 近一年 | 3.90% | 1512/3446 |
| 近两年 | 40.64% | 1509/2399 |
| 近三年 | 50.20% | 424/1802 |
| 成立以来 | 58.29% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.85% 2929/4961 |
-8.54% 3892/5312 |
- - |
- - |
| 2025 | 11.01% 2768/4813 |
2.60% 1314/3635 |
12.12% 114/4076 |
-8.84% 4061/4524 |
5.86% 395/4813 |
| 2024 | 41.33% 13/3463 |
10.54% 54/2808 |
7.25% 92/3014 |
12.97% 2267/3129 |
5.52% 596/3463 |
| 2023 | -2.47% 583/2656 |
-2.62% 2026/2280 |
2.17% 159/2385 |
5.03% 102/2515 |
-6.67% 1871/2655 |
| 2022 | -4.79% 107/2207 |
2.24% 65/1919 |
-1.61% 1744/2016 |
-8.49% 202/2113 |
3.43% 693/2208 |
| 2021 | -0.95% 771/1822 |
10.46% 38/1255 |
-2.58% 1217/1330 |
-7.39% 1049/1466 |
-0.62% 1254/1822 |
| 2020 | 0.80% 937/1250 |
-14.70% 970/1028 |
2.32% 974/1067 |
5.39% 922/1164 |
9.59% 631/1184 |
| 2019 | 26.76% 568/1092 |
16.33% 673/754 |
2.64% 78/804 |
-0.76% 614/850 |
6.98% 508/918 |
| 2018 | -12.05% 80/834 |
- - |
- - |
- - |
-9.54% 149/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 华宝中证银行ETF VS. 长安沪深300非周期A(740101) |